Add like
Add dislike
Add to saved papers

Treatment of actual effluents produced in the manufacturing of atrazine by a photo-electrolytic process.

Chemosphere 2017 April
The photo-assisted electrochemical degradation of a real effluent of the atrazine manufacturing process containing atrazine, simazine, hydroxy-triazine and propazine was carried out galvanostatically using a pilot-scale tubular flow reactor prototype containing DSA(®) and Ti as cathode. The effluent was mainly characterized by a high amount of NaCl, required in the synthesis route used, and it was used as taken in the factory. The variables for process optimization were the current density (3.0, 6.0, and 9.0 mA cm(-2)) and flow rate (300 and 3,000 L h(-1)). These later values produces laminar and turbulent flow regimes, with Reynolds numbers of 1,100 and 11,000, respectively. None of the four organics contained in the waste is refractory to the photo-electrochemical treatment and they are depleted with the photo-electrolytic technology using large current densities and appropriate electric charge passed. Both direct electrochemical process and mediated anodic oxidation occur during the treatment. First process occurs at turbulent flow condition and low current densities, while the chemical oxidation process happens at laminar flow condition and high current densities. Atrazine and propazine are efficiently removed at laminar flow conditions, with an almost total depletion for the largest current densities. On the contrary, simazine is efficiently removed in turbulent flow conditions and intermediate current density, with removals higher than 90% for 20 kWh m(-3). These results have great significance because they demonstrate the applicability of the electrochemical technology in the treatment of real industrial wastes with a cell specially designed to attain high efficiency in the removal of pollutants.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app